Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients.

Ali HR, Provenzano E, Dawson SJ, Blows FM, Liu B, Shah M, Earl HM, Poole CJ, Hiller L, Dunn JA, Bowden SJ, Twelves C, Bartlett JM, Mahmoud SM, Rakha E, Ellis IO, Liu S, Gao D, Nielsen TO, Pharoah PD, Caldas C.

Ann Oncol. 2014 Aug;25(8):1536-43. doi: 10.1093/annonc/mdu191. Epub 2014 Jun 9.

PMID:
24915873
[PubMed - in process]
Free Article
2.

Diagnostic value of next-generation sequencing in an unusual sphenoid tumor.

Jamshidi F, Pleasance E, Li Y, Shen Y, Kasaian K, Corbett R, Eirew P, Lum A, Pandoh P, Zhao Y, Schein JE, Moore RA, Rassekh R, Huntsman DG, Knowling M, Lim H, Renouf DJ, Jones SJ, Marra MA, Nielsen TO, Laskin J, Yip S.

Oncologist. 2014 Jun;19(6):623-30. doi: 10.1634/theoncologist.2013-0390. Epub 2014 May 7.

PMID:
24807916
[PubMed - in process]
3.

Expression of the EGF family in gastric cancer: downregulation of HER4 and its activating ligand NRG4.

Nielsen TO, Friis-Hansen L, Poulsen SS, Federspiel B, Sorensen BS.

PLoS One. 2014 Apr 11;9(4):e94606. doi: 10.1371/journal.pone.0094606. eCollection 2014.

PMID:
24728052
[PubMed - in process]
Free PMC Article
4.

The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.

Filipits M, Nielsen TO, Rudas M, Greil R, Stöger H, Jakesz R, Bago-Horvath Z, Dietze O, Regitnig P, Gruber-Rossipal C, Müller-Holzner E, Singer CF, Mlineritsch B, Dubsky P, Bauernhofer T, Hubalek M, Knauer M, Trapl H, Fesl C, Schaper C, Ferree S, Liu S, Cowens JW, Gnant M; Austrian Breast and Colorectal Cancer Study Group.

Clin Cancer Res. 2014 Mar 1;20(5):1298-305. doi: 10.1158/1078-0432.CCR-13-1845. Epub 2014 Feb 11.

PMID:
24520097
[PubMed - in process]
5.

Co-expression of HER3 and MUC1 is associated with a favourable prognosis in bladder cancer patients.

Nielsen TO, Borre M, Nexo E, Sorensen BS.

BJU Int. 2014 Jan 28. doi: 10.1111/bju.12658. [Epub ahead of print]

PMID:
24467768
[PubMed - as supplied by publisher]
6.

HER4 and its cytoplasmic isoforms are associated with progression-free survival of malignant melanoma.

Nielsen TO, Poulsen SS, Journe F, Ghanem G, Sorensen BS.

Melanoma Res. 2014 Feb;24(1):88-91. doi: 10.1097/CMR.0000000000000040.

PMID:
24366194
[PubMed - in process]
7.

PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients.

Jørgensen CL, Nielsen TO, Bjerre KD, Liu S, Wallden B, Balslev E, Nielsen DL, Ejlertsen B.

Acta Oncol. 2014 Jun;53(6):776-87. doi: 10.3109/0284186X.2013.865076. Epub 2013 Dec 20.

PMID:
24359601
[PubMed - in process]
8.

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.

Gnant M, Filipits M, Greil R, Stoeger H, Rudas M, Bago-Horvath Z, Mlineritsch B, Kwasny W, Knauer M, Singer C, Jakesz R, Dubsky P, Fitzal F, Bartsch R, Steger G, Balic M, Ressler S, Cowens JW, Storhoff J, Ferree S, Schaper C, Liu S, Fesl C, Nielsen TO; Austrian Breast and Colorectal Cancer Study Group.

Ann Oncol. 2014 Feb;25(2):339-45. doi: 10.1093/annonc/mdt494. Epub 2013 Dec 16.

PMID:
24347518
[PubMed - in process]
9.

Activating transcription factor 2 in mesenchymal tumors.

Endo M, Su L, Nielsen TO.

Hum Pathol. 2014 Feb;45(2):276-84. doi: 10.1016/j.humpath.2013.09.003. Epub 2013 Nov 27.

PMID:
24289970
[PubMed - indexed for MEDLINE]
10.

Myxoid liposarcoma in a 91-year-old patient.

Sheffield BS, Nielsen TO.

Mol Cytogenet. 2013 Nov 19;6(1):50. doi: 10.1186/1755-8166-6-50.

PMID:
24252207
[PubMed]
Free PMC Article
11.

An international Ki67 reproducibility study.

Polley MY, Leung SC, McShane LM, Gao D, Hugh JC, Mastropasqua MG, Viale G, Zabaglo LA, Penault-Llorca F, Bartlett JM, Gown AM, Symmans WF, Piper T, Mehl E, Enos RA, Hayes DF, Dowsett M, Nielsen TO; International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group.

J Natl Cancer Inst. 2013 Dec 18;105(24):1897-906. doi: 10.1093/jnci/djt306. Epub 2013 Nov 7.

PMID:
24203987
[PubMed - indexed for MEDLINE]
12.

Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort.

Chapman JA, Nielsen TO, Ellis MJ, Bernard P, Chia S, Gelmon KA, Pritchard KI, Le Maitre A, Goss PE, Leung S, Shepherd LE, Bramwell VH.

Breast Cancer Res. 2013;15(4):R71.

PMID:
23972025
[PubMed - in process]
Free PMC Article
13.

Reply to Y.Yamamoto et al.

Prat A, Martin M, Nielsen TO, Perou CM.

J Clin Oncol. 2013 Jul 1;31(19):2517-8. No abstract available.

PMID:
23967491
[PubMed - indexed for MEDLINE]
14.

A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard.

Won JR, Gao D, Chow C, Cheng J, Lau SY, Ellis MJ, Perou CM, Bernard PS, Nielsen TO.

Mod Pathol. 2013 Nov;26(11):1438-50. doi: 10.1038/modpathol.2013.97. Epub 2013 May 24.

PMID:
23702728
[PubMed - indexed for MEDLINE]
15.

Directing HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivo.

Nielsen TO, Sorensen S, Dagnæs-Hansen F, Kjems J, Sorensen BS.

Br J Cancer. 2013 Jun 11;108(11):2291-8. doi: 10.1038/bjc.2013.247. Epub 2013 May 21.

PMID:
23695025
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer.

Prat A, Cheang MC, Martín M, Parker JS, Carrasco E, Caballero R, Tyldesley S, Gelmon K, Bernard PS, Nielsen TO, Perou CM.

J Clin Oncol. 2013 Jan 10;31(2):203-9. doi: 10.1200/JCO.2012.43.4134. Epub 2012 Dec 10.

PMID:
23233704
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription-polymerase chain reaction in formalin-fixed, paraffin-embedded tumor.

Isphording A, Ali RH, Irving J, Goytain A, Nelnyk N, Hoang LN, Gilks CB, Huntsman DG, Nielsen TO, Nucci MR, Lee CH.

Hum Pathol. 2013 May;44(5):837-43. doi: 10.1016/j.humpath.2012.08.007. Epub 2012 Nov 15.

PMID:
23159154
[PubMed - indexed for MEDLINE]
18.

PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.

Bastien RR, Rodríguez-Lescure Á, Ebbert MT, Prat A, Munárriz B, Rowe L, Miller P, Ruiz-Borrego M, Anderson D, Lyons B, Álvarez I, Dowell T, Wall D, Seguí MÁ, Barley L, Boucher KM, Alba E, Pappas L, Davis CA, Aranda I, Fauron C, Stijleman IJ, Palacios J, Antón A, Carrasco E, Caballero R, Ellis MJ, Nielsen TO, Perou CM, Astill M, Bernard PS, Martín M.

BMC Med Genomics. 2012 Oct 4;5:44. doi: 10.1186/1755-8794-5-44.

PMID:
23035882
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.

Lee CH, Ali RH, Rouzbahman M, Marino-Enriquez A, Zhu M, Guo X, Brunner AL, Chiang S, Leung S, Nelnyk N, Huntsman DG, Blake Gilks C, Nielsen TO, Dal Cin P, van de Rijn M, Oliva E, Fletcher JA, Nucci MR.

Am J Surg Pathol. 2012 Oct;36(10):1562-70.

PMID:
22982899
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Pazopanib for metastatic soft-tissue sarcoma.

Endo M, Nielsen TO.

Lancet. 2012 Sep 1;380(9844):801; author reply 801. doi: 10.1016/S0140-6736(12)61440-8. No abstract available.

PMID:
22939674
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk